La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Micro-X Bilan de santé

Santé financière contrôle des critères 6/6

Micro-X has a total shareholder equity of A$10.0M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$21.6M and A$11.6M respectively.

Informations clés

Ratio d'endettement

AU$0

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	AU$5.31m
Fonds propres	AU$9.96m
Total du passif	AU$11.61m
Total des actifs	AU$21.57m

Mises à jour récentes de la santé financière

Recent updates

Take Care Before Diving Into The Deep End On Micro-X Limited (ASX:MX1)

Jun 24

Micro-X Limited (ASX:MX1) Doing What It Can To Lift Shares

Mar 12

Sentiment Still Eluding Micro-X Limited (ASX:MX1)

Jul 14

Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?

May 02

Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why

Nov 07

We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully

Jul 07

Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation

Mar 01

What We Learned About Micro-X's (ASX:MX1) CEO Pay

Jan 29

What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?

Jan 08

Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?

Dec 18

Micro-X Limited's (ASX:MX1) Shift From Loss To Profit

Nov 27

Analyse de la situation financière

Passif à court terme: MX1's short term assets (A$14.3M) exceed its short term liabilities (A$6.9M).

Passif à long terme: MX1's short term assets (A$14.3M) exceed its long term liabilities (A$4.7M).

Historique et analyse du ratio d'endettement

Niveau d'endettement: MX1 is debt free.

Réduire la dette: MX1 currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: MX1 has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.

Prévisions de trésorerie: MX1 is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.

Micro-X Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?

We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully

Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation

Micro-X Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Take Care Before Diving Into The Deep End On Micro-X Limited (ASX:MX1)

Micro-X Limited has completed a Follow-on Equity Offering in the amount of AUD 3.9 million.

New minor risk - Shareholder dilution

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million.

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

New minor risk - Share price stability

Micro-X Limited (ASX:MX1) Doing What It Can To Lift Shares

Micro-X Reveals First Look At New Mobile Stroke Diagnosis Device

Consensus revenue estimates fall by 20%

Price target decreased by 11% to AU$0.25

New minor risk - Profitability

Micro-X Limited, Annual General Meeting, Nov 16, 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Financial data availability

Non-Executive Director exercised options to buy AU$174k worth of stock.

Sentiment Still Eluding Micro-X Limited (ASX:MX1)

Forecast breakeven date pushed back to 2025

Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.008 loss per share (vs AU$0.019 loss in 1H 2022)

Less than half of directors are independent

Micro-X Limited announced that it has received AUD 7.454223 million in funding from Varex Imaging Corporation

Less than half of directors are independent

Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why

Consensus forecasts updated

Less than half of directors are independent

Micro-X Limited, Annual General Meeting, Nov 14, 2022

Micro-X Limited Announces Resignation of Yasmin King as Director

Micro-X Limited announced that it expects to receive AUD 7.454223 million in funding from Varex Imaging Corporation

Micro-X Limited Launches Next Generation Micro-X Rover, the Rover Plus

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to AU$0.36

We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully

Price target decreased to AU$0.51

Micro-X Ltd Appoints Ilona Meyer to Its Board as A Non-Executive Director and Member of the Micro-X Audit & Risk Committee, Effective 7Th March 2022

Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation

Consensus forecasts updated

Consensus revenue estimates fall by 34%

Full year 2021 earnings released: AU$0.037 loss per share (vs AU$0.043 loss in FY 2020)

Consensus revenue estimates fall to AU$4.20m

Micro-X Ltd Launches New Version of the Rover Mobile DR for Use in Small-Animal Veterinary Hospitals

Micro-X Limited Announces Rover FDA Approval Opens US Healthcare Market

Consensus forecasts updated

Analysts update estimates

First half 2021 earnings released: AU$0.013 loss per share (vs AU$0.025 loss in 1H 2020)

New 90-day high: AU$0.40

Micro-X Limited announced that it expects to receive AUD 30.5 million in funding

What We Learned About Micro-X's (ASX:MX1) CEO Pay

What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?

New 90-day high: AU$0.39

Micro-X Limited Signs $1.3 Million Rover Contract for Australian Defence Force

Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?

Micro-X Limited Announces Rejoining of Jim McDowell as Non-Executive Director from January 1, 2021

New 90-day high: AU$0.36

Micro-X Limited's (ASX:MX1) Shift From Loss To Profit

Price target raised to AU$0.50

Micro-X Limited Amends Nano Distribution Agreement with Carestream Health Inc

Micro-X Ltd Announces Management Changes

New 90-day high: AU$0.26

Analysts update estimates

Micro-X Limited Signs $1.4 Million Contract for Rover Launches Micro-X Second Product

New 90-day high: AU$0.21

Micro-X Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.043 loss per share

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines